How People Undergoing Genomic Sequencing Interpret and React to Varied Secondary Findings with Limited Actionability
May 23, 2025
The purpose of this study was to investigate patient reactions and understanding of secondary genomic findings with limited to no medical actionability (LMA-SFs) from diagnostic genome sequencing. Gail E. Henderson, PhD, analyzed LMA-SFs returned to 47 adults who elected to receive a broad set of these results from six categories....